Details of the Drug

General Information of Drug (ID: DM8I4HO)

Drug Name

Recombinant botulinum neurotoxin vaccine

Indication

Disease Entry	ICD 11	Status	REF
Migraine	8A80	Phase 3	[1]
------------------------------------------------------------------------------------

Cross-matching ID

References

1	ClinicalTrials.gov (NCT01940315) Phase 3, Randomized, Safety, Lot Consistency and Clinical Benefit Study of Recombinant Botulinum Vaccine A/B. U.S. National Institutes of Health.